Back

Clinical value of anti-fibrotic strategies.

25 May 2019 (11:45 - 12:00)
Organised by:
Congress Presentation Part of: Anti-fibrotic therapies in heart failure. Cardiac Diseases HFA Premium Access Heart Failure 2019

About the speaker

Photo
Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)

3 More presentations in this session

Presentation thumbnail
Myocardial fibrosis: new concepts.
Professor S. Heymans (Maastricht, NL)
Slides Video
Presentation thumbnail
Targeting the cellular origin of cardiac fibrosis.
Professor J. Hulot (Paris, FR)
Slides Video
Presentation thumbnail
Natural compounds to treat cardiac fibrosis.
Professor T. Thum (Hannover, DE)

Access the full session

Session thumbnail
Anti-fibrotic therapies in heart failure.

The Event

Event poster

Heart Failure 2019

25 May 2019 11:45 CET
You may be interested in
thumbnail
Congress Presentation
Pirfenidone added to standard therapy for myocardial infarction further reduces left ventricular fibrosis: a preclinical study
21 May 2022
thumbnail
Congress Session
Breaking the pressure: innovations in pulmonary hypertension management
18 May 2025
thumbnail
Congress Session
Update on antiarrhythmic therapy
31 March 2025
thumbnail
Congress Presentation
Silencing RNA to treat heart failure and cardiomyopathy
10 May 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources